RA Capital Management »

Parabilis Medicines shares owned by RA Capital Management

Quarter-by-quarter ownership of Parabilis Medicines shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $792M 29M 27.37

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Parabilis Medicines

RA Capital Management
Arch Venture Corp
venBio Partners
Nextech Invest
Regeneron Pharmaceuticals
Jupiter Topco
Soleus Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co
Alliancebernstein
VR Adviser
Samsara BioCapital
Baker Bros. Advisors
Marshall Wace

View all funds holding Parabilis Medicines